Method for treating a cancer with a mixed ligand gold(III) complexes as Anti-cancer agents

a technology of mixed ligands and anti-cancer agents, which is applied in the field of pharmaceutical compounds, can solve problems such as unstable gold(iii) complexes

Inactive Publication Date: 2017-03-16
KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present patent is about a new gold(III) complex and its use in treating cancer. The complex has specific formulas and can be in solid, semi-solid or liquid forms. It can be administered to patients through various modes of administration such as oral, systemic, and injection. The complex has been found to be effective in treating prostate and gastrointestinal cancers, as well as being resistant to cisplatin. It can also inhibit the proliferation of cancer cells. The technical effects of this patent are the new gold(III) complex and its use in treating cancer.

Problems solved by technology

In general, gold(III) complexes are unstable under physiological conditions because they have a high reduction potential and hydrolyze fast.
Therefore, selecting suitable ligands to enhance the stability of gold(III) complexes is a challenge.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for treating a cancer with a mixed ligand gold(III) complexes as Anti-cancer agents
  • Method for treating a cancer with a mixed ligand gold(III) complexes as Anti-cancer agents
  • Method for treating a cancer with a mixed ligand gold(III) complexes as Anti-cancer agents

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of Gold(III) Complexes

[0117]Sodium tetrachloroaurate(III) dihydrate NaAuCl4.2H2O and 1,3-propylenediamine (pn) were purchased from Sigma-Aldrich. Ligands, cis-1,2-diaminocyclohexane (cis-DACH), trans-(±)-1,2-diaminocyclohexane (trans-(±)-DACH) and (S,S)-(+)-diaminocyclohexane ((S,S)-DACH) were purchased from Aldrich. Absolute C2HsOH, CH3OH, D2O and DMSO-d6 were obtained from Fluka Chemicals Co. All other reagents as well as solvents were obtained from Aldrich Chemical Co., and used as received.

[0118]Mixed ligand gold(III) chloride compounds, cis-1,2-diaminocyclohexane(1,3-propylenediamine)gold(III) chloride, [(pn)Au {cis-(1,2-DACH)} ]Cl3 1, trans-(±)-1,2-diaminocyclohexane(1,3-propylenediamine)gold(III) chloride, [(pn)Au {(trans-(±)-(1,2-DACH)}]Cl3 2, and (S,S)-(+)-1,2-diaminocyclohexane(1,3-propylenediamine)gold(III) chloride [(pn)Au {(S,S)-(+)-(1,2-DACH)} ]Cl3 3, were synthesized using one mole of sodium tetrachloroaurate(III) dihydrate NaAuCl4.2H2O with one mole of 1,3-...

example 2

Electronic Spectra

[0120]Electronic spectra were obtained for the gold(III) complexes using the Lambda 200, Perkin-Elmer UV-Vis spectrometer. UV-Vis spectroscopy was used to determine the stability of the complexes in a physiological buffer (40 mM phosphate, 4 mM NaCl, pH 7.4). Electronic spectra were recorded on freshly prepared of each complex in buffer solution at room temperature. Then, their electronic spectra were monitored over 3 days at 37° C. The UV-Vis absorption data is shown in Table 2.

TABLE 2λmax values derived from UV-Vis spectrafor gold(III) complexes 1, 2 and 3.Complexλmax (nm)NaAuCl4293133223393341

[0121]The gold(III) complexes 1, 2 and 3 dissolved in a reference buffered phosphate solution exhibit intense absorptions in the range 332-341 nm, which are assigned to ligand-to-metal charge-transfer (LMCT) transitions characteristically associated to the gold(III) center [Esumi K, Nawa M, Aihara N, Usui K (1998) New J. Chem. 20:719-720—incorporated herein by reference in ...

example 3

Mid and Far-IR Studies

[0124]The IR spectra of the ligands and their gold(III) complexes were recorded on a Perkin-Elmer FT-IR 180 spectrophotometer using KBr pellets over the range 4000-400 cm−1. The selected IR frequencies are given in Table 3.

TABLE 3IR frequencies, ν(cm−1) for cyclohexanediamine-gold(III)-propylenediamine complexes.Complexν(N—H)νshiftν(C—N)νshiftRefs.pn3357 m, 3282 m1093 wd(pn)AuCl33447 br1271178 s 85dcis-1,2-(DACH)3356 m, 3286 m3092s  e[cis-1,2-(DACH)AuCl2]Cl3414 w931183 s 91e1 3426br, 3106 br105a, 107b1163w 71a, 70bctrans-(±)-1,2-(DACH)3348 m, 3271 m, 3183 m1082 me[trans-(±)-1,2-(DACH)AuCl2]Cl3485 w, 3420 w, 3384 w137, 149, 2011175 m93e23452br, 3112 br131a, 133b1184 m92a, 91bc(S,S)-(+)-1,2-(DACH)3340 m, 3252 m, 3167 m1082 me[(S,S)-(+)-1,2-(DACH)AuCl2]Cl3604 m, 3340 m, 3306 m, 3168 m132, 27 1171 m89e33444br, 3118    123a, 125b1186 m94a, 93bcawith respect to DACH,bwith respect to pn,c this work,d Al-Maythalony B A et al. (2009) Inorg. Chim. Acta. 362: 3109-3113 - ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Gold(III) complexes with mixed ligands as anticancer agents. The gold(III) cations are coordinated to bidentate ligands having diamino functional groups: a diaminocyclohexane ligand and a 1,3-propylenediamine ligand. The diaminocyclohexane ligand can exist in both cis- and trans-configurations, resulting in isomeric gold(III) complexes. Also described are pharmaceutical compositions incorporating the gold(III) complexes, methods of synthesis, methods of treating cancer and methods of inhibiting cancer cell proliferation and inducing cancer cell apoptosis.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a continuation of Ser. No. 14 / 850,063, now allowed.STATEMENT OF FUNDING ACKNOWLEDGEMENT[0002]This project was funded by the National Plan for Science, Technology and Innovation (MAARIFAH)—King Abdulaziz City for Science and Technology—the Kingdom of Saudi Arabia, award number (14-MED64-04).BACKGROUND OF THE INVENTION[0003]Technical Field[0004]The present invention relates to pharmaceutical compounds. More particularly, the present invention relates to gold(III) complexes having mixed diamine ligands. The present invention includes the use of these gold(III) complexes for treatment of cancers and cell proliferative disorders.[0005]Description of the Related Art[0006]The “background” description provided herein is for the purpose of generally presenting the context of the disclosure. Work of the presently named inventors, to the extent it is described in this background section, as well as aspects of the description whic...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & AuthorityApplications(United States)
IPC IPC(8): A61K31/28
CPCA61K31/28C07F1/005A61K45/06C07F1/12
InventorAL-JAROUDI, SAIDALTAF, MUHAMMADAL-SAADI, ABDULAZIZISAB, ANVARHUSEIN ABDULKADIR
OwnerKING FAHD UNIVERSITY OF PETROLEUM AND MINERALS